Yes. Daunorubicin is a vesicant (irritant) and can cause severe tissue damage upon extravasation (leaking of injected Daunorubicin into the surrounding tissues from the site of administration) when injected.

Daunorubicin is used in combination with other cancer medications to subside the progression of different types of blood cancers such as cancer of the white blood cells (acute myeloid and acute lymphocytic leukemia).

Daunorubicin comes as a solution or powder to be added to fluid and injected into a vein (intravenous) along with other chemotherapy medications. It is given as an injection by a cancer specialized doctor (oncologist) who is experienced in giving chemotherapy medications for cancer in a hospital or a clinic.

The frequency and duration of Daunorubicin treatment depends on the other chemotherapy medications you are taking, how well your body responds to them, and the type of cancer you have. Your doctor will decide the dose and frequency for you based on different parameters. For any doubts, consult your doctor.

Daunorubicin is an anti-cancer drug which belongs to the class of medicines called anthracycline cytotoxic antibiotics. The exact mechanism for its clinical effects is not clear; however multiple mechanisms directly interfering with important DNA processes and cell division are thought to be responsible for slowing or stopping the growth of cancer cells.